TD Private Client Wealth LLC Has $5.68 Million Holdings in Kenvue Inc. $KVUE

Key Points

• TD Private Client Wealth LLC has reduced its stake in Kenvue Inc. by 13.7%, now holding shares worth approximately $5.68 million.
• Kenvue recently decreased its quarterly dividend to $0.2075 per share, marking an increase from the previous amount and reflecting a yield of 4.8%.
• Kenvue's stock has seen analysts set a range of new price targets, with recent adjustments bringing estimates between $22.00 to $27.00, indicating a cautious outlook amidst varying ratings.

TD Private Client Wealth LLC trimmed its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 13.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 271,202 shares of the company's stock after selling 43,178 shares during the period. TD Private Client Wealth LLC's holdings in Kenvue were worth $5,676,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its stake in Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock valued at $5,494,882,000 after acquiring an additional 10,600,682 shares during the period. Third Point LLC bought a new stake in shares of Kenvue during the first quarter valued at approximately $213,422,000. Maverick Capital Ltd. acquired a new position in shares of Kenvue in the first quarter valued at $203,036,000. Nuveen LLC bought a new position in Kenvue in the first quarter worth $187,123,000. Finally, Voya Investment Management LLC boosted its stake in Kenvue by 131.3% during the first quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company's stock worth $290,557,000 after buying an additional 6,886,784 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on KVUE shares. Royal Bank Of Canada reduced their price objective on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a report on Friday, August 8th. Zacks Research raised Kenvue to a "strong sell" rating in a report on Monday, August 11th. Bank of America lowered their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th. Barclays dropped their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 15th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Four research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $23.32.

Kenvue Price Performance

Kenvue stock opened at $17.26 on Wednesday. The business's fifty day moving average is $20.69 and its two-hundred day moving average is $21.96. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The firm has a market cap of $33.11 billion, a P/E ratio of 23.32, a P/E/G ratio of 2.44 and a beta of 0.83. Kenvue Inc. has a 52 week low of $16.89 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 4.8%. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio (DPR) is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.